Methadone: applications in pediatric anesthesiology and critical care medicine

Joseph D Tobias1

  • 1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital and The Ohio State University, 700 Children's Drive, Columbus, OH , 43205, USA. Joseph.Tobias@Nationwidechildrens.org.

Journal of Anesthesia
|January 12, 2021
PubMed

Insights

Methadone, a long-acting µ-opioid receptor agonist, offers versatile pain management. Its unique pharmacology also targets NMDA receptors and neurotransmitter reuptake, benefiting pediatric anesthesiology and critical care.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Methadone is a pure µ-opioid receptor agonist, similar to morphine but with a significantly longer elimination half-life (24-36 hours vs. 2-3 hours).
  • Beyond µ-opioid agonism, methadone exhibits unique pharmacological actions including N-methyl-D-aspartate (NMDA) receptor antagonism and inhibition of serotonin and norepinephrine reuptake in the central nervous system.

Purpose of the Study:

  • To review the pharmacologic properties of methadone.
  • To discuss the clinical applications of methadone in pediatric anesthesiology and pediatric critical care medicine.

Main Methods:

  • Literature review of methadone's pharmacologic properties.
  • Analysis of clinical applications in pediatric pain management and critical care.

Main Results:

  • Methadone's long half-life and high oral bioavailability facilitate outpatient treatment for opioid abuse.
  • Its multifaceted pharmacology makes it effective for managing diverse acute and chronic pain conditions.

Conclusions:

  • Methadone's unique pharmacologic profile supports its use beyond opioid addiction treatment.
  • The manuscript highlights methadone's value in pediatric anesthesiology and critical care settings.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
425
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
665
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
108
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.2K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
592